Barclays Maintains Overweight on LivaNova, Raises Price Target to $120
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Christopher Pasquale maintains LivaNova (NASDAQ:LIVN) with a Overweight and raises the price target from $105 to $120.
Barclays analyst Christopher Pasquale maintains LivaNova (NASDAQ:LIVN) with a Overweight and raises the price target from $105 to $120.